Literature DB >> 20696773

Protein kinase CK1alphaLS promotes vascular cell proliferation and intimal hyperplasia.

Mikhail P Panchenko1, Zakir Siddiquee, David M Dombkowski, Yuriy O Alekseyev, Marc E Lenburg, Jennifer D Walker, Thomas E Macgillivray, Frederic I Preffer, James R Stone.   

Abstract

Protein kinase CK1alpha regulates several fundamental cellular processes including proliferation and differentiation. Up to four forms of this kinase are expressed in vertebrates resulting from alternative splicing of exons; these exons encode either the L-insert located within the catalytic domain or the S-insert located at the C terminus of the protein. Whereas the L-insert is known to target the kinase to the nucleus, the functional significance of nuclear CK1alphaLS has been unclear. Here we demonstrate that selective L-insert-targeted short hairpin small interfering RNA-mediated knockdown of CK1alphaLS in human vascular endothelial cells and vascular smooth muscle cells impairs proliferation and abolishes hydrogen peroxide-stimulated proliferation of vascular smooth muscle cells, with the cells accumulating in G(0)/G(1). In addition, selective knockdown of CK1alphaLS in cultured human arteries inhibits vascular activation, preventing smooth muscle cell proliferation, intimal hyperplasia, and proteoglycan deposition. Knockdown of CK1alphaLS results in the harmonious down-regulation of its target substrate heterogeneous nuclear ribonucleoprotein C and results in the altered expression or alternative splicing of key genes involved in cellular activation including CXCR4, MMP3, CSF2, and SMURF1. Our results indicate that the nuclear form of CK1alpha in humans, CK1alphaLS, plays a critical role in vascular cell proliferation, cellular activation, and hydrogen peroxide-mediated mitogenic signal transduction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696773      PMCID: PMC2928985          DOI: 10.2353/ajpath.2010.100327

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

1.  Four casein kinase I isoforms are differentially partitioned between nucleus and cytoplasm.

Authors:  Z Fu; T Chakraborti; S Morse; G S Bennett; G Shaw
Journal:  Exp Cell Res       Date:  2001-10-01       Impact factor: 3.905

2.  A small molecule CXCR4 antagonist inhibits neointima formation and smooth muscle progenitor cell mobilization after arterial injury.

Authors:  E Karshovska; D Zagorac; A Zernecke; C Weber; A Schober
Journal:  J Thromb Haemost       Date:  2008-07-19       Impact factor: 5.824

3.  Effect of overexpression of very low density lipoprotein receptor on cell growth.

Authors:  Y Wada; Y Homma; K Nakazato; T Ishibashi; Y Maruyama
Journal:  Heart Vessels       Date:  2000       Impact factor: 2.037

4.  Redox regulation of chemokine receptor expression.

Authors:  A Saccani; S Saccani; S Orlando; M Sironi; S Bernasconi; P Ghezzi; A Mantovani; A Sica
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

5.  Transcriptional down-regulation of CXC chemokine receptor 4 induced by impaired association of transcription regulator YY1 with c-Myc in human herpesvirus 6-infected cells.

Authors:  A Hasegawa; M Yasukawa; I Sakai; S Fujita
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

6.  GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions.

Authors:  Su-Ning Zhu; Mian Chen; Jenny Jongstra-Bilen; Myron I Cybulsky
Journal:  J Exp Med       Date:  2009-09-14       Impact factor: 14.307

Review 7.  Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities.

Authors:  Shane R Thomas; Paul K Witting; Grant R Drummond
Journal:  Antioxid Redox Signal       Date:  2008-10       Impact factor: 8.401

8.  Increased expression of cellular RNA-binding proteins in HPV-induced neoplasia and cervical cancer.

Authors:  Joanna Fay; Peter Kelehan; Helen Lambkin; Stefan Schwartz
Journal:  J Med Virol       Date:  2009-05       Impact factor: 2.327

9.  Up-regulation of a hydrogen peroxide-responsive pre-mRNA binding protein in atherosclerosis and intimal hyperplasia.

Authors:  Mikhail P Panchenko; Nilsa Silva; James R Stone
Journal:  Cardiovasc Pathol       Date:  2008-05-27       Impact factor: 2.185

10.  Ancestral vascular lumen formation via basal cell surfaces.

Authors:  Tomás Kucera; Boris Strilić; Kathrin Regener; Michael Schubert; Vincent Laudet; Eckhard Lammert
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

View more
  6 in total

Review 1.  A Smurf1 tale: function and regulation of an ubiquitin ligase in multiple cellular networks.

Authors:  Yu Cao; Lingqiang Zhang
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

Review 2.  Current siRNA targets in the prevention and treatment of intimal hyperplasia.

Authors:  Leena Pradhan-Nabzdyk; Chenyu Huang; Frank W LoGerfo; Christoph S Nabzdyk
Journal:  Discov Med       Date:  2014-09       Impact factor: 2.970

3.  Dynamic regulatory network reconstruction for Alzheimer's disease based on matrix decomposition techniques.

Authors:  Wei Kong; Xiaoyang Mou; Xing Zhi; Xin Zhang; Yang Yang
Journal:  Comput Math Methods Med       Date:  2014-06-15       Impact factor: 2.238

Review 4.  Casein kinase 1α: biological mechanisms and theranostic potential.

Authors:  Shaojie Jiang; Miaofeng Zhang; Jihong Sun; Xiaoming Yang
Journal:  Cell Commun Signal       Date:  2018-05-24       Impact factor: 5.712

Review 5.  SMURF1, a promoter of tumor cell progression?

Authors:  Qin Xia; Yang Li; Da Han; Lei Dong
Journal:  Cancer Gene Ther       Date:  2020-11-17       Impact factor: 5.987

6.  Selective compounds enhance osteoblastic activity by targeting HECT domain of ubiquitin ligase Smurf1.

Authors:  Yuan Zhang; Cheng Wang; Yu Cao; Yongqing Gu; Lingqiang Zhang
Journal:  Oncotarget       Date:  2016-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.